News & Events

12-22-22 Notice of Public Hearing CD Ramsay

12/12/22

Application
CBA

NOTICE IS HEREBY GIVEN that a public hearing pursuant to Article 18-A of the New York State General Municipal Law will be held by the Town of Brookhaven Industrial Development Agency (the “Agency”) on the 22nd day of December, 2022, at 10:00 a.m. local time, at the Town of Brookhaven Town Hall, Industrial Development Agency, 1 Independence Hill, Farmingville, New York 11738, in connection with the following matters:

The Agency has previously provided its assistance to CD Ramsay Realty, LLC, a limited liability company organized and existing under the laws of the State of New York, on behalf of itself and/or the principals of CD Ramsay Realty, LLC and/or an entity formed or to be formed on behalf of the foregoing (collectively, the “Company”); Creative Biomart Inc, a business corporation organized and existing under the laws of the State of New York, on behalf of itself and/or the principals of Creative Biomart Inc and/or an entity formed or to be formed on behalf of the foregoing (collectively, “Creative Biomart”); Creative Biolabs Inc, a business corporation organized and existing under the laws of the State of New York, on behalf of itself and/or the principals of Creative Biolabs Inc and/or an entity formed or to be formed on behalf of the foregoing (collectively, “Creative Biolabs”); Creative Dynamics, Inc., a business corporation organized and existing under the laws of the State of New York, on behalf of itself and/or the principals of Creative Dynamics, Inc. and/or an entity formed or to be formed on behalf of the foregoing (collectively, “Creative Dynamics”); CD Biosciences Inc, a business corporation organized and existing under the laws of the State of New York, on behalf of itself and/or the principals of CD Biosciences Inc and/or an entity formed or to be formed on behalf of the foregoing (collectively, “CD Biosciences”); and BOCSCI Inc, a business corporation organized and existing under the laws of the State of New York, on behalf of itself and/or the principals of BOCSCI Inc and/or an entity formed or to be formed on behalf of the foregoing (collectively, “BOCSCI”; and together with Creative Biomart, Creative Biolabs, Creative Dynamics and CD Biosciences, the “Sublessees”); in: (a) the acquisition of an approximately 4.5-acre parcel of vacant land, located at Ramsay Road and Precision Drive, Shirley, New York 11967 (more particularly described as Suffolk County Tax Map No. 0200-584.00-01.00- 004.040) (the “Land”), the construction of an approximately 12,000 square foot building thereon (the “Original Improvements”), and the acquisition and installation therein of certain equipment and personal property not part of the Original Equipment (as such term is defined herein) (the “Original Facility Equipment”; and together with the Improvements, the “Original Company Facility”), which Original Company Facility is leased by the Agency to the Company and subleased by the Company to the Sublessees; (b) the acquisition and installation of certain equipment and personal property (the “Original Creative Biomart Equipment”), which Original Creative Biomart Equipment is leased by the Agency to Creative Biomart; (c) the acquisition and installation of certain equipment and personal property (the “Original Creative Biolabs Equipment”), which Original Creative Biolabs Equipment is leased by the Agency to Creative Biolabs; (d) the acquisition and installation of certain equipment and personal property (the “Original Creative Dynamics Equipment”), which Original Creative Dynamics Equipment is leased by the Agency to Creative Dynamics; (e) the acquisition and installation of certain equipment and personal property (the “Original CD Biosciences Equipment”), which Original CD Biosciences Equipment is leased by the Agency to CD Biosciences; and (f) the acquisition and installation of certain equipment and personal property (the “Original BOCSCI Equipment”; and together with the Original Creative Biomart Equipment, the Original Creative Biolabs Equipment, the Original Creative Dynamics Equipment and the Original CD Biosciences Equipment, the “Original Equipment”), which Original BOCSCI Equipment is leased by the Agency to BOCSCI (the Original Company Facility and the Original Equipment shall be collectively known as the “Original Facility”), and which Original Facility is used by the Sublessees as laboratory and office space for the following purposes: the distribution of various proteins to the life sciences research community; providing protein expression and purification services; the distribution of antibody and antibody library services; the distribution of high quality recombinant proteins, antibodies, antigens, enzymes and ELISA assays to researchers in biology, clinical research, molecular diagnostics and biopharmaceutical drug development and related fields; the distribution of biopharmaceutical products, antibacterial pharmaceutical products, oncology products and vaccines; and providing personalized solutions for the conjugation of small molecules such as drugs, metabolites and labeled compounds with synthetic or natural compounds for synthetic applications (the “Original Project”).

The Company has submitted a request to the Agency for financial assistance, in connection with (a) the construction and equipping of an approximately 18,500 square foot building to be located on the Land (the “2022 Improvements”, and together with the Original Improvements, the “Improvements”), and the acquisition and installation therein of certain equipment and personal property not part of the 2022 Equipment (as such term is defined herein) (the “2022 Facility Equipment”, and the 2022 Company Facility together with the Original Company Facility, the “Company Facility”), which 2022 Company Facility will be leased by the Agency to the Company and subleased by the Company to the Sublessees; (b) the acquisition and installation of certain equipment and personal property (the “2022 Creative Biomart Equipment”), which 2022 Creative Biomart Equipment is to be leased by the Agency to Creative Biomart, (c) the acquisition and installation of certain equipment and personal property (the “2022 Creative Biolabs Equipment”), which 2022 Creative Biolabs Equipment is to be leased by the Agency to Creative Biolabs; (d) the acquisition and installation of certain equipment and personal property (the “2022 Creative Dynamics Equipment”), which 2022 Creative Dynamics Equipment is to be leased by the Agency to Creative Dynamics; (e) the acquisition and installation of certain equipment and personal property (the “2022 CD Biosciences Equipment”), which 2022 CD Biosciences Equipment is leased by the Agency to CD Biosciences; and (f) the acquisition and installation of certain equipment and personal property (the “2022 BOCSCI Equipment”; and together with the 2022 Creative Biomart Equipment, the 2022 Creative Biolabs Equipment, the 2022 Creative Dynamics Equipment and the 2022 CD Biosciences Equipment, the “2022 Equipment”, and the 2022 Equipment together with the Original Equipment, the “Equipment”, and the 2022 Equipment together with the 2022 Company Facility, the “2022 Facility”, and the 2022 Facility together with the Original Facility, the “Facility”) which 2022 BOCSCI Equipment is to be leased by the Agency to BOCSCI, and the 2022 Facility is to be used by the Company and Sublessees as an additional laboratory in their current business as a manufacturer and distributer of biologic proteins for the biotech industry (the “2022 Project”, and together with the Original Project, the “Project”). The 2022 Facility will be initially owned, operated and/or managed by the Company and the Sublessees.

The Agency has previously acquired a leasehold interest in the Original Facility, and will continue to lease the Original Company Facility to the Company and lease the Original Equipment to the Sublessees. The Agency contemplates that it will continue to provide financial assistance to the Company in the form of exemptions from mortgage recording taxes in connection with the financing or any subsequent refinancing of the Facility, exemptions from sales and use taxes and the modification and extension of current abatements of real property taxes, consistent with the policies of the Agency.

A representative of the Agency will, at the above-stated time and place, hear and accept written comments from all persons with views in favor of or opposed to either the proposed financial assistance to the Company and the Sublessees or the location or nature of the 2022 Facility. Prior to the hearing, all persons will have the opportunity to review on the Agency’s website (https://brookhavenida.org/), the application for financial assistance filed by the Company and the Sublessees with the Agency and an analysis of the costs and benefits of the proposed 2022 Facility.

Dated: December 12, 2022
TOWN OF BROOKHAVEN INDUSTRIAL DEVELOPMENT AGENCY
By: Lisa MG Mulligan
Title: Chief Executive Officer 

< Back To All Posts

Contact Us

  • One Independence Hill
    Farmingville, New York 11738

  • Tel: 631-451-6563
    Fax: 631-451-6925

  • Brookhaven IDA

  • www.brookhavenida.org